主动脉瓣狭窄 Resources for Health Care 专业人士

Together, we can make a difference.

The 目标:主动脉瓣狭窄 quality improvement program exists to enhance the patient experience from symptom onset to appropriate diagnosis and follow-through, to timely 治疗 and disease management. See below for guideline, clinical and patient educational resources.

指导资源:

Valvular Heart Disease Guidelines (网站)

Key Implications for Clinicians in the 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease

In your evaluation of patients with suspected valvular heart disease, learn the diagnostic strategies for early detection of valvular disease and appropriate long-term management. Discover appropriate tools for assessment and intervention based on valvular disease stage, specifically in cases of mitral regurgitation and aortic stenosis.

启动网络研讨会

Resources mentioned in the webinar

临床资料:

Thanks to the facilities participating in the 目标:主动脉瓣狭窄 program, several key areas have been identified along the patient journey where barriers to care exist. 这些关键领域包括: 

  • Identification of patients diagnosed with moderate or severe aortic stenosis
  • Once identified, urgently moving the patient through the journey to appropriate definitive 治疗
  • Variations in the multidisciplinary and shared decision-making process

To learn more regarding the 目标:主动脉瓣狭窄 program and the suggested best practices and solutions from experts in the field addressing these barrier to care, please see the resources below.  

Does Your Hospital 目标:主动脉瓣狭窄? Learn How to 参与

AHA’s newest quality program, 目标:主动脉瓣狭窄, and hear from phase 1 pilot sites who overcame barriers in identifying their initial patient population.

目标:主动脉瓣狭窄 Update

Highlights from a recent publication and hear from one of our newest sites.

播客:
Under治疗 of 主动脉瓣狭窄, a Deadly Heart Valve Disease

心脏播客图标

This episode discusses under治疗 of aortic stenosis, one of the most common and serious – but undertreated – heart valve diseases. Hear from two experts on the subject: Dr. 布莱恩·林德曼，M.D., 摩根士丹利资本国际(MSCI), medical director of the Structural Heart and Valve Center at Vanderbilt University Medical Center, 博士和. Sammy Elmariah, M.D., MPH, chief of interventional cardiology and UCSF Health. Tune in to learn about the consequences of undertreating aortic stenosis, 可能的解决方案, 和更多的. Under治疗 of 主动脉瓣狭窄, a Deadly Heart Valve Disease


播客: Under治疗 of 主动脉瓣狭窄, a Deadly Heart Valve Disease

新! Current Management of 主动脉瓣狭窄: A Guideline-Based Approach
加入博士. Michael Mack, Medical Director, Cardiothoracic Surgery for Baylor Scott & White and Chairman of BSW The Heart Hospital, Plano Research Center as he discusses current management of 主动脉瓣狭窄. Some of the best practices and solutions discussed in this video include:

  • The need to facilitate access to care in underserved populations
  • No follow-up after echo – examples of 可能的解决方案
  • Evaluation of those with suspected heart disease – specific examples of testing
  • Clinical decision making – a multi-disciplinary heart team approach
  • 共同决策 – Who should be included and factors
  • Treatment decisions – specific algorithm that is guideline based
  • Testing recommendations after AVR

Download 演讲 Slides on Current Management of 主动脉瓣狭窄

Under治疗 of 主动脉瓣狭窄: A Conversation to Understand the Problem and Consider Solutions

加入博士. 布赖恩·林德曼博士. Sammy Elmariah and a diverse group of experts from across the country – representing interventional cardiology, 超声心动图, surgery and nursing perspectives as they address the under治疗 of patients with aortic stenosis. Some of the best practices and 治疗s discussed in this video include:

  • The use of class 1 recommendations for AVR – a guideline-based approach
  • Team-based care necessity
  • Increasing accuracy and decreasing variability in echo reports
    • Categorization based on totality of evidence, not just valve area
    • Utilizing two sonographers reading report
    • Specific language in conclusion in summary report in bold
    • Group review on reads on regular basis to reduce variability
  • All AVRs should go to Heart Valve Team, including SAVRs, to make sure the choices are discussed
  • 共同决策
  • The need for a structured process to move patient quickly to definitive 治疗
  • Referring patients early and use a team approach within a system
  • Need for Artificial Intelligence (AI) and digital strategies for patient surveillance
  • Building relationships through outreach and feedback
  • Echo reporting techniques
    • Electronic notification to ordering physician
    • Highlight guideline recommendations and need for 推荐
  • Move to a screening point of care echo based on age
  • Artificial intelligence (AI) based evaluation of ECGs to identify

Download 演讲 Slides on Under治疗 of 主动脉瓣狭窄

National Introduction to the American Heart Association's Initiative, 目标:主动脉瓣狭窄™

加入博士. Clyde Yancy, Northwestern Memorial Hospital an Dr. J. 马修·布伦南, Duke Triangle Heart Associates, as they introduce you to the American Heart Association’s national initiative, 目标:主动脉瓣狭窄. 在这次演讲中，Dr. Brennan will outline the issues surrounding the 主动脉瓣狭窄 patient pathway, including detection and gaps in diagnosis, 推荐, 治疗, 公众意识, 以及护理方面的差异. Dr. Yancy reviews what the AHA is doing to address these issues with our new pilot program built on the framework of our longstanding and trusted heart and vascular quality programs. Edwards Lifesciences is the national sponsor of American Heart Association’s 目标:主动脉瓣狭窄. Some of the best practices and 治疗s discussed in this video include:

  • Valve Replacement means higher quality of life as well as reducing the cost of care
  • Need for more 公众意识 – coordinated nationally and locally
  • Need to increase accuracy of stethoscope use
  • Move forward with echocardiogram in patients with unexplained murmurs
  • Need for routine surveillance
  • Need multiple doppler views for appropriate severity grading
  • Evaluate full spectrum of echo criteria when determining severity
  • Must exercise stress test and use biomarkers for asymptomatic patients
  • 共同决策 must include effective patient education
  • Delay in 推荐 directly impacts survival rates
Download 演讲 Slides on 目标:主动脉瓣狭窄™
Written by American Heart Association editorial staff and reviewed by science and medicine advisors.

See our editorial policies and staff.

赞助商

Edwards Lifesciences is the national sponsor of American Heart Association’s 目标:主动脉瓣狭窄.

赞助商
Learn more about Edwards Lifesciences